1. Lee JH, Kang SY, Yoo Y, An J, Park SY, Lee JH, et al. Epidemiology of adult chronic cough: disease burden, regional issues, and recent findings. Asia Pac Allergy. 2021; 11(4):e38. PMID:
34786368.
Article
2. Morice AH, Millqvist E, Belvisi MG, Bieksiene K, Birring SS, Chung KF, et al. Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J. 2014; 44(5):1132–1148. PMID:
25142479.
Article
3. Song WJ, Chung KF. Exploring the clinical relevance of cough hypersensitivity syndrome. Expert Rev Respir Med. 2020; 14(3):275–284. PMID:
31914340.
Article
4. Song WJ, An J, McGarvey L. Recent progress in the management of chronic cough. Korean J Intern Med. 2020; 35(4):811–822. PMID:
32422697.
Article
5. Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Domingo Ribas C, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020; 55(1):1901136. PMID:
31515408.
Article
6. Eddy NB, Friebel H, Hahn KJ, Halbach H. Codeine and its alternates for pain and cough relief. 3. The antitussive action of codeine--mechanism, methodology and evaluation. Bull World Health Organ. 1969; 40(3):425–454. PMID:
4896168.
7. Dicpinigaitis PV, Morice AH, Birring SS, McGarvey L, Smith JA, Canning BJ, et al. Antitussive drugs--past, present, and future. Pharmacol Rev. 2014; 66(2):468–512. PMID:
24671376.
Article
8. Zanasi A, Lanata L, Fontana G, Saibene F, Dicpinigaitis P, De Blasio F. Levodropropizine for treating cough in adult and children: a meta-analysis of published studies. Multidiscip Respir Med. 2015; 10(1):19. PMID:
26097707.
Article
9. Yancy WS Jr, McCrory DC, Coeytaux RR, Schmit KM, Kemper AR, Goode A, et al. Efficacy and tolerability of treatments for chronic cough: a systematic review and meta-analysis. Chest. 2013; 144(6):1827–1838. PMID:
23928798.
Article
10. Song DJ, Song WJ, Kwon JW, Kim GW, Kim MA, Kim MY, et al. KAAACI evidence-based clinical practice guidelines for chronic cough in adults and children in Korea. Allergy Asthma Immunol Res. 2018; 10(6):591–613. PMID:
30306744.
Article
11. Sato S, Saito J, Sato Y, Ishii T, Xintao W, Tanino Y, et al. Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough. Respir Med. 2008; 102(10):1452–1459. PMID:
18614345.
Article
12. Oh MJ, Lee JY, Lee BJ, Choi DC. Exhaled nitric oxide measurement is useful for the exclusion of nonasthmatic eosinophilic bronchitis in patients with chronic cough. Chest. 2008; 134(5):990–995. PMID:
18583518.
Article
13. Kwon JW, Moon JY, Kim SH, Song WJ, Kim MH, Kang MG, et al. Korean version of the Cough Symptom Score: clinical utility and validity for chronic cough. Korean J Intern Med. 2017; 32(5):910–915. PMID:
28352059.
Article
14. Kwon JW, Moon JY, Kim SH, Song WJ, Kim MH, Kang MG, et al. Reliability and validity of a Korean version of the Leicester Cough Questionnaire. Allergy Asthma Immunol Res. 2015; 7(3):230–233. PMID:
25749761.
Article
15. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003; 58(4):339–343. PMID:
12668799.
Article
16. Hsu JY, Stone RA, Logan-Sinclair RB, Worsdell M, Busst CM, Chung KF. Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder. Eur Respir J. 1994; 7(7):1246–1253. PMID:
7925902.
Article
17. Martin Nguyen A, Bacci ED, Vernon M, Birring SS, Rosa C, Muccino D, et al. Validation of a visual analog scale for assessing cough severity in patients with chronic cough. Ther Adv Respir Dis. 2021; 15:17534666211049743. PMID:
34697975.
Article
18. Spinou A, Birring SS. An update on measurement and monitoring of cough: what are the important study endpoints? J Thorac Dis. 2014; 6(Suppl 7):S728–S734. PMID:
25383207.
19. Raj AA, Pavord DI, Birring SS. Clinical cough IV:what is the minimal important difference for the Leicester Cough Questionnaire? Handb Exp Pharmacol. 2009; 187(187):311–320.
Article
20. Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician. 2008; 11(2):Suppl. S133–S153. PMID:
18443637.
Article
21. Morice AH, Menon MS, Mulrennan SA, Everett CF, Wright C, Jackson J, et al. Opiate therapy in chronic cough. Am J Respir Crit Care Med. 2007; 175(4):312–315. PMID:
17122382.
Article
22. Singu B, Verbeeck RK. Should codeine still be considered a WHO essential medicine? J Pharm Pharm Sci. 2021; 24:329–335. PMID:
34192509.
Article
23. Gaedigk A, Sangkuhl K, Whirl-Carrillo M, Klein T, Leeder JS. Prediction of CYP2D6 phenotype from genotype across world populations. Genet Med. 2017; 19(1):69–76. PMID:
27388693.
Article
24. Luporini G, Barni S, Marchi E, Daffonchio L. Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancer. Eur Respir J. 1998; 12(1):97–101. PMID:
9701421.
Article
25. James A, Williams J. Basic opioid pharmacology - an update. Br J Pain. 2020; 14(2):115–121. PMID:
32537150.
Article
26. Smith JA, Badri H. Cough: new pharmacology. J Allergy Clin Immunol Pract. 2019; 7(6):1731–1738. PMID:
31279461.
Article
27. Roe NA, Lundy FT, Litherland GJ, McGarvey LP. Therapeutic targets for the treatment of chronic cough. Curr Otorhinolaryngol Rep. 2019; 7(2):116–128.
Article
28. Abdulqawi R, Dockry R, Holt K, Layton G, McCarthy BG, Ford AP, et al. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet. 2015; 385(9974):1198–1205. PMID:
25467586.
29. Eccles R. The powerful placebo effect in cough: relevance to treatment and clinical trials. Lung. 2020; 198(1):13–21. PMID:
31834478.
Article